| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/29/2010 | WO2010083872A2 Materials for organic electroluminescence devices |
| 07/29/2010 | WO2010083649A1 Bisarylurea derivatives and their use |
| 07/29/2010 | WO2010065802A3 Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds |
| 07/29/2010 | WO2010065799A3 Amine substituted piperidine melanocortin receptor-specific compounds |
| 07/29/2010 | WO2010056059A3 Novel crystalline dexlansoprazole and pharmaceutical composition comprising same |
| 07/29/2010 | WO2010045212A3 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 07/29/2010 | WO2010044585A3 Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 07/29/2010 | WO2010042925A3 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 07/29/2010 | WO2010039545A3 1,2-benzisothiazolinone and isoindolinone derivatives |
| 07/29/2010 | WO2009158467A3 Di-substituted phenyl compounds as phosphodiesterase 10 inhibitors |
| 07/29/2010 | WO2009158257A4 Fungicidal pyridines |
| 07/29/2010 | US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity |
| 07/29/2010 | US20100190989 Process for the preparation of pure rabeprazole |
| 07/29/2010 | US20100190988 Process for preparation of pyrazole derivatives |
| 07/29/2010 | US20100190979 Diacylglycerol acyltransferase inhibitors |
| 07/29/2010 | US20100190977 4-phenylamino-quinazolin-6-yl-amides |
| 07/29/2010 | US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives |
| 07/29/2010 | US20100190827 treating diseases responsive to cannabinoid receptor antagonism; using particular crystallization conditions, a novel stable crystalline form called form II is obtained |
| 07/29/2010 | US20100190825 Benzimidazoles which have activity at m1 receptor and their uses in medicine |
| 07/29/2010 | US20100190823 Therapeutic ((Bicylicheteroaryl)Imidazolyl) Methylheteroaryl Compounds |
| 07/29/2010 | US20100190822 Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV) |
| 07/29/2010 | US20100190812 Nilotinib hcl crystalline forms |
| 07/29/2010 | US20100190811 Pyrimidine derivatives and compositions as c-kit and pdgfr kinase inhibitors |
| 07/29/2010 | US20100190801 Triazolopyridine derivatives as inhibitors of lipases and phospholipases |
| 07/29/2010 | US20100190789 Piperidine/piperazine derivatives |
| 07/29/2010 | US20100190788 Amide derivatives as kinase inhitors |
| 07/29/2010 | US20100190783 Triazolone derivatives |
| 07/29/2010 | US20100190780 Sigma receptor inhibitors |
| 07/29/2010 | US20100190779 Viral polymerase inhibitors |
| 07/29/2010 | US20100190773 Anti-Cytokine Heterocyclic Compounds |
| 07/29/2010 | US20100190768 Novel fused pyrole derivative |
| 07/29/2010 | US20100190763 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors |
| 07/29/2010 | US20100190762 Triazolyl phenyl benzenesulfonamides |
| 07/29/2010 | US20100190761 Diphenyl substituted alkanes |
| 07/29/2010 | US20100190746 Quinazolinones as potassium channel modulators |
| 07/29/2010 | US20100190745 Heterocyclic urea derivatives and methods of use thereof |
| 07/29/2010 | US20100190230 Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors with Improved Membrane Permeability |
| 07/29/2010 | US20100187978 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same |
| 07/29/2010 | US20100187520 Light emitting device material and light emitting device |
| 07/29/2010 | US20100187505 Benzanthracene derivatives for organic electroluminescent devices |
| 07/29/2010 | CA2749700A1 Benzodiazepin-2-on derivatives |
| 07/29/2010 | CA2749217A1 Compositions and methods for inhibition of the jak pathway |
| 07/29/2010 | CA2748587A1 Substituted pyrazinone amides |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210886A1 Pyrimidyl indoline compound |
| 07/28/2010 | EP2210885A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 07/28/2010 | EP2210876A1 Heterocyclic compound |
| 07/28/2010 | EP2209774A1 Pyrimidinedione derivatives |
| 07/28/2010 | EP2209761A1 Diphenyl substituted cycloalkanes |
| 07/28/2010 | EP2209376A1 Novel seh inhibitors and their use |
| 07/28/2010 | EP2209373A1 N-substituted oxindoline derivatives as calcium channel blockers |
| 07/28/2010 | EP2086939B1 Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 07/28/2010 | EP2076494B1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 07/28/2010 | EP2029546B1 Aryl-substituted heterocycles, and use thereof |
| 07/28/2010 | EP1838314B1 Process for preparing lansoprazole |
| 07/28/2010 | EP1694668B1 4-[(arylmethyl)aminomethyl]piperidine derivatives, preparation thereof and application of same in therapeutics |
| 07/28/2010 | EP1633746B1 New indole derivatives as factor xa inhibitors |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | EP1369418B1 Quinazoline derivatives |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1788000B Phthalazinone derivatives |
| 07/28/2010 | CN101790525A pharmaceutical compounds |
| 07/28/2010 | CN101790524A 抗病毒化合物 Antiviral compounds |
| 07/28/2010 | CN101790522A Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 07/28/2010 | CN101790521A Substituted piperazines as cb1 antagonists |
| 07/28/2010 | CN101790516A Novel substituted piperidones as hsp inducers |
| 07/28/2010 | CN101787019A Quinazoline derivatives |
| 07/28/2010 | CN101787016A Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 07/28/2010 | CN101787015A Chiral tricyclic compounds with anti-histamine activity, preparation method and application |
| 07/28/2010 | CN101786993A 1, 2, 3-triazole compound and application thereof in preparing indoleamine 2, 3-dioxygenase inhibitor |
| 07/28/2010 | CN101786992A 2-hydroxymethyl-3,5,6-trimethylpyrazine derivatives, preparation methods and application thereof |
| 07/27/2010 | US7763727 electrophotographic photoconductor, an organic transistor, an organic electroluminescent device and an organic solar cell; naphthalene monoimide derivative, naphthalene monoimide monohydrazone derivative |
| 07/27/2010 | US7763639 1-ethyl-4-[2-fluoro-3-(methylsulfonyl)phenyl]piperidine, havinf therapeutic effects against disorders in the central nervous system, such as dyskinesia |
| 07/27/2010 | US7763638 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 07/27/2010 | US7763632 administering drugs succh as N-[2-diethylamino-5-{N-ethyl-N-(trifluoroacetyl)amino}pyrimidin-4-yl]-L-4'-{(pyrrolidin-1-yl) carbonyloxy}phenylalanine, for the treament asthma, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease, graft versus host disease and arthritis |
| 07/27/2010 | US7763631 substituted amino pyrimidine derivatives useful in the treatment or prevention of viral infections, in particular against human immunodeficiency virus (HIV), which is the aetiological agent of acquired immune deficiency syndrome (AIDS) in humans |
| 07/27/2010 | US7763627 2-pyridin-4-ylquinazolin-4- amine's such as N-cyclohexyl-2-pyridin-4-ylquinazolin-4- amine, used as tyrosine kinase inhibitors, for modulating cellular activities such as proliferation, differentiation, apoptosis, migration and chemoinvasion; antiproliferative agents and angiogenesis inhibitors |
| 07/27/2010 | US7763621 3-[[6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-2,5-dimethyl-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine, used for the treatment of osteoporosis, restenosis, arteriosclerosis, nephropathy or retinopathy |
| 07/27/2010 | US7763617 Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient |
| 07/27/2010 | US7763616 Chemokine receptor antagonists, used for the treatment of inflammatory diseases, autoimmune diseases, transplant rejection, infectious diseases, hypersensitivity responses, ophthalmic inflammation, diabetes, viral meningitis and tumors |
| 07/27/2010 | US7763614 Isoquinoline potassium channel inhibitors |
| 07/27/2010 | US7763608 Factor Xa inhibitors |
| 07/27/2010 | US7763602 Drug resistant Mycobacterium tuberculosis |
| 07/27/2010 | US7763236 administering a formulation in the form of a toothpaste, mouthwash, mouth spray or chewing gum, comprising osteopontin effective to inhibit plaque bacterial growth on teeth enamel |
| 07/27/2010 | CA2610166C Benzoquinolinesulfonamide derivatives useful as rho-kinase inhibitors |
| 07/27/2010 | CA2595815C Salt form of a dopamine agonist |
| 07/27/2010 | CA2481241C Fused quinoxaline derivatives as inhibitors of akt activity |
| 07/27/2010 | CA2466560C Acetylene derivatives having mglur5 antagonistic activity |
| 07/27/2010 | CA2461060C Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof |
| 07/22/2010 | WO2010082563A1 Cyclic compound having hetero atom |
| 07/22/2010 | WO2010082044A1 Unsaturated bicyclic heterocyclic derivatives as smo antagonists |
| 07/22/2010 | WO2010081904A1 4 ( 1h) -pyridinone derivatives and their use as antimalaria agents |
| 07/22/2010 | WO2010081900A1 Quinolinone derivatives useful for the treatment of cns disorders |
| 07/22/2010 | WO2010081851A1 Piperidin-4-ylpiperazine compounds for the treatment of hcv infection |
| 07/22/2010 | WO2010081783A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/22/2010 | WO2010081666A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 07/22/2010 | WO2010065743A3 Bicyclic compounds and methods of making and using same |
| 07/22/2010 | WO2010039518A3 Tricyclic carbamate jak inhibitors |
| 07/22/2010 | WO2010037059A3 Heteroaryl antagonists of prostaglandin d2 receptors |
| 07/22/2010 | WO2010036629A3 Fused multicyclic compounds as protein kinase inhibitors |